Evidence map›Paper›PMID 30659274›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2019

Occupancy of dopamine D

Patricia Di Ciano, Esmaeil Mansouri, Junchao Tong, Alan A Wilson, Sylvain Houle, Isabelle Boileau, Thierry Duvauchelle, Philippe Robert, Jean Charles Schwartz, Bernard Le Foll

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Effect of scan-time shortening on theAnnals of nuclear medicine · 2023
    Article
  6. Dopamine DJournal of medicinal chemistry · 2023
    Article
  7. Review
  8. ECEuropean journal of nuclear medicine and molecular imaging · 2022
    Article
  9. The role of neuroimaging in Parkinson's disease.Journal of neurochemistry · 2021
    Review
  10. Review
  11. Separating dopamine DNeuroImage · 2020
    Article
  12. Article
  13. D3 dopamine receptors and a missense mutation of fatty acid amide hydrolase linked in mouse and men: implication for addiction.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2020
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Patricia Di CianoTranslational Addiction Research Laboratory, Centre for Addiction and Mental Health, 33 Russell Street, Toronto, ON, M5S 2S1, Canada.
Esmaeil MansouriAddiction Imaging Research Group, Centre for Addiction and Mental Health, Toronto, ON, M5S 2S1, Canada.
Junchao TongPreclinical imaging, Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, ON, M5S 2S1, Canada.
Alan A WilsonInstitute of Medical Sciences, University of Toronto, Toronto, Canada.
Sylvain HouleInstitute of Medical Sciences, University of Toronto, Toronto, Canada.
Isabelle BoileauAddiction Imaging Research Group, Centre for Addiction and Mental Health, Toronto, ON, M5S 2S1, Canada.
Thierry DuvauchelleBioprojet, Paris, France.
Philippe RobertBioprojet Biotech, Saint Grégoire, France.
Jean Charles SchwartzBioprojet, Paris, France.
Bernard Le FollTranslational Addiction Research Laboratory, Centre for Addiction and Mental Health, 33 Russell Street, Toronto, ON, M5S 2S1, Canada. Bernard.lefoll@camh.ca.
Centre for Addiction and Mental Health · CABioprojet (France) · FRUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There has been considerable interest in the development of dopamine D3 receptor (DRD

Indexed as

AdultBrainDopamine AgonistsDose-Response Relationship, DrugDrug Partial AgonismFemaleHumansMaleOxazinesPositron-Emission TomographyReceptors, Dopamine D2Receptors, Dopamine D3Dopamine AgonistsDRD2 protein, humannaxagolideOxazinesReceptors, Dopamine D2Receptors, Dopamine D3

Identifiers

PMID30659274
PMCPMC6785153
OpenAlexW2902728380

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.